Query: NC_010556:71776 Exiguobacterium sibiricum 255-15, complete genome Lineage: Exiguobacterium sibiricum; Exiguobacterium; Bacillales Family XII; Bacillales; Firmicutes; Bacteria General Information: This organism was isolated from a 2-3 million-year permafrost core in Siberia, Russia and can survive and grow rapidly at low temperatures. Analysis of long-term survival of psychrophilic organisms such as this one may aid understanding of the potential growth of organisms in astrobiology. Exiguobacterium sibiricum is a psychrotolerant organism able to grow at temperatures that range from -6 to 40 degrees C. This organism is also able to survive repeated freeze/thaw cycles which may contribute to its ability to survive in cold environments.
- Sequence; - BLASTP hit: hover for score (Low score = Light, High score = Dark); - hypothetical protein; - cds: hover for description
General Information: This strain was isolated in 1994 in the USA from a patient with duodenal ulcer. This genus consists of organisms that colonize the mucosal layer of the gastrointestinal tract or are found enterohepatically (in the liver). It was only recently discovered (1983) by two Australians (Warren and Marshall) that this organism was associated with peptic ulcers. It is one of the most common chronic infectious organisms, and is found in half the world's population. This organism attacks the gastric epithilial surface, resulting in chronic gastritis, and can cause more severe diseases including those that lead to gastric carcinomas and lymphomas, peptic ulcers, and severe diarrhea. It is an extracellular pathogen that persists in the gastric environment, which has a very low pH, by production of the urease enzyme, which converts urea to ammonia and carbon dioxide, a process which can counteract the acidic environment by production of a base. The toxins include cytolethal distending toxin, vacuolating cytotoxin (VacA) that induces host epithelial cell apopoptosis (cell death), and the cytotoxin associated antigen (CagA) which results in alteration to the host cell signalling pathways. The CagA protein is translocated into host cells by a type IV secretion system encoded by the cag pathogenicity island.